Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

Abstract

Meningococcal disease is an infection caused by Neisseria meningitidis. Genetic factors contribute to host susceptibility and progression to disease, but the genes responsible for disease development are largely unknown1,2,3. We report here a genome-wide association study for host susceptibility to meningococcal disease using 475 individuals with meningococcal disease (cases) and 4,703 population controls from the UK. We performed, in Western European and South European cohorts (consisting of 968 cases and 1,376 controls), two replication studies for the most significant SNPs. A cluster of complement factor SNPs replicated independently in both cohorts, including SNPs within complement factor H (CFH) (rs1065489 (p.936D<E), P = 2.2 × 10−11) and in CFH-related protein 3 (CFHR3)(rs426736, P = 4.6 × 10−13). N. meningitidis is known to evade complement-mediated killing by the binding of host CFH to the meningococcal factor H–binding protein (fHbp)4. Our study suggests that host genetic variation in these regulators of complement activation plays a role in determining the occurrence of invasive disease versus asymptomatic colonization by this pathogen.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regional association plot of the CFH cluster.
Figure 2: Linkage disequilibrium plot of the CFH cluster on chromosome 1.

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Emonts, M., Hazelzet, J.A., de Groot, R. & Hermans, P.W. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3, 565–577 (2003).

    Article  CAS  Google Scholar 

  2. Haralambous, E. et al. Sibling familial risk ratio of meningococcal disease in UK Caucasians. Epidemiol. Infect. 130, 413–418 (2003).

    Article  CAS  Google Scholar 

  3. Wright, V., Hibberd, M. & Levin, M. Genetic polymorphisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 27 Suppl 2, B90–B102 (2009).

    Article  CAS  Google Scholar 

  4. Schneider, M.C. et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 458, 890–893 (2009).

    Article  CAS  Google Scholar 

  5. van Deuren, M., Brandtzaeg, P. & van der Meer, J.W. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin. Microbiol. Rev. 13, 144–166 (2000).

    Article  CAS  Google Scholar 

  6. Mathew, S. & Overturf, G.D. Complement and properidin deficiencies in meningococcal disease. Pediatr. Infect. Dis. J. 25, 255–256 (2006).

    Article  Google Scholar 

  7. Newport, M.J. et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335, 1941–1949 (1996).

    Article  CAS  Google Scholar 

  8. Smirnova, I. et al. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. USA 100, 6075–6080 (2003).

    Article  CAS  Google Scholar 

  9. Hibberd, M.L., Sumiya, M., Summerfield, J.A., Booy, R. & Levin, M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group. Lancet 353, 1049–1053 (1999).

    Article  CAS  Google Scholar 

  10. Haralambous, E. et al. Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand. J. Infect. Dis. 38, 764–771 (2006).

    Article  CAS  Google Scholar 

  11. Haralambous, E. et al. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit. Care Med. 31, 2788–2793 (2003).

    Article  CAS  Google Scholar 

  12. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).

  13. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).

    Article  CAS  Google Scholar 

  14. Harrison, L.H., Trotter, C.L. & Ramsay, M.E. Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2, B51–B63 (2009).

    Article  Google Scholar 

  15. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).

    Article  Google Scholar 

  16. Zipfel, P.F. et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 3, e41 (2007).

    Article  Google Scholar 

  17. Hughes, A.E. et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 38, 1173–1177 (2006).

    Article  CAS  Google Scholar 

  18. Male, D.A., Ormsby, R.J., Ranganathan, S., Giannakis, E. & Gordon, D.L. Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Mol. Immunol. 37, 41–52 (2000).

    Article  CAS  Google Scholar 

  19. Klein, R.J. et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385–389 (2005).

    Article  CAS  Google Scholar 

  20. Abarrategui-Garrido, C., Martinez-Barricarte, R., Lopez-Trascasa, M., de Cordoba, S.R. & Sanchez-Corral, P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 114, 4261–4271 (2009).

    Article  CAS  Google Scholar 

  21. Brouwer, M.C. et al. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis. 9, 31–44 (2009).

    Article  CAS  Google Scholar 

  22. Hazelzet, J.A. Diagnosing meningococcemia as a cause of sepsis. Pediatr. Crit. Care Med. 6, S50–S54 (2005).

    Article  Google Scholar 

  23. Nadel, S., Newport, M.J., Booy, R. & Levin, M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174, 878–880 (1996).

    Article  CAS  Google Scholar 

  24. Geishofer, G. et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia. Eur. J. Pediatr. 164, 486–490 (2005).

    Article  CAS  Google Scholar 

  25. Binder, A. et al. Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia. Hum. Genet. 122, 183–190 (2007).

    Article  CAS  Google Scholar 

  26. Hermans, P.W. et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 354, 556–560 (1999).

    Article  CAS  Google Scholar 

  27. Burgner, D. et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 5, e1000319 (2009).

    Article  Google Scholar 

  28. Salas, A., Fachal, L., Marcos-Alonso, S., Vega, A. & Martinon-Torres, F. Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease. PLoS ONE 4, e8347 (2009).

    Article  Google Scholar 

  29. Hollox, E.J., Barber, J.C., Brookes, A.J. & Armour, J.A. Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 18, 1686–1697 (2008).

    Article  CAS  Google Scholar 

  30. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C.H. Wong, D. Tan, J.W. Tay, W.Y. Meah, S. Rajaram and C.B. Ang (Genome Institute of Singapore) for technical and logistical assistance. We also would like to thank all the children and parents who participated in this study. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website (see URLs). Funding for the project was provided by the Wellcome Trust under award 085475 (UK). The present work has been supported in part by funding from the Agency for Science and Technology and Research of Singapore (A*STAR) (Singapore). The UK meningococcal disease cohort was established with grant support from the Meningitis Research Foundation (UK). The coordination of the European cohorts was supported by a grant from the European Society for Pediatric Infectious Diseases. The Western Europe study was supported by grants no 8842, 10112 and 12710 of the Oesterreichische Nationalbank (Austria), grants A3-16.K-8/2008-11 and A3-16.K-8/2006-9 of the Department for Science and Research of the Styrian federal government (Austria) and the nonprofit association 'In Vita', Graz (Austria). The ESIGEM research group activities were supported by grants from Xunta de Galicia (PGIDIT06PXIB208079PR and Grupos Emerxentes: 2008/037), Fundación de Investigación Médica Mutua Madrileña (2008/CL444) and Ministerio de Ciencia e Innovación (SAF2008-02971) given to A.S.; Consellería de Sanidade (Xunta de Galicia, RHI07/2-intensificación actividad investigadora), Instituto Carlos III (Intensificación de la actividad investigadora), Convenio de colaboración de investigación (Wyeth España-Fundación IDICHUS 2007-2010), Fondo de Investigación Sanitaria (FIS; PI070069) del plan nacional de I+D+I and 'fondos FEDER' given to F.M.-T. M.E. was financially supported by the Erasmus MC Revolving Fund Foundation (RF 2001/24) (The Netherlands).

Author information

Authors and Affiliations

Consortia

Contributions

M.L. and M.L.H. conceived the study. S.D., V.J.W., M.L. and M.L.H. designed the study. V.J.W. and C.C.L. performed the experiments. S.D., V.J.W., C.C.K. and K.S.S. analyzed the data. A.B., W.B.B., D.I., S.N., H.B., E.D.C., R.d.G., P.W.M.H., J.H., M.E., T.W.K., F.M.T., A.S. and W.Z. coordinated national subject cohorts with collaborating clinicians (listed in the Supplementary Note) including sample collection and clinical data collection. S.D., V.J.W., C.C.K., M.L. and M.L.H. wrote the first draft of the manuscript. All authors contributed to the final version of the manuscript.

Corresponding authors

Correspondence to Sonia Davila, Michael Levin or Martin L Hibberd.

Ethics declarations

Competing interests

The author declare no competing financial interests.

Additional information

A full list of members is provided in the Supplementary Note.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–6, Supplementary Tables 1–6 and Supplementary Note (PDF 4679 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

the International Meningococcal Genetics Consortium. Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet 42, 772–776 (2010). https://doi.org/10.1038/ng.640

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.640

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing